The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2020

Filed:

Dec. 20, 2016
Applicants:

Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, Jiangsu, CN;

Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;

Inventors:

Xiangdong Qu, Shanghai, CN;

Xin Ye, Shanghai, CN;

Shaoyu Xu, Shanghai, CN;

Bei Yuan, Shanghai, CN;

Dongbing Cui, Shanghai, CN;

Qiyue Hu, Shanghai, CN;

Lei Zhang, Shanghai, CN;

Zhibin Xu, Shanghai, CN;

Weikang Tao, Shanghai, CN;

Lianshan Zhang, Shanghai, CN;

Piaoyang Sun, Jiangsu, CN;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); C12N 9/64 (2006.01); A61K 39/395 (2006.01); A61P 3/06 (2006.01); C12N 15/62 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61P 3/06 (2018.01); C12N 9/64 (2013.01); C12N 15/62 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.


Find Patent Forward Citations

Loading…